Re: A Biopsy-Based 17-Gene Genomic Prostate Score Predicts Recurrence after Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low-and Intermediate-Risk Prostate Cancer

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 05期
关键词：
D O I：
10.1016/j.juro.2015.02.070
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1541 / 1541
页数：1
相关论文
共 22 条
  • [1] A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
    Cullen, Jennifer
    Rosner, Inger L.
    Brand, Timothy C.
    Zhang, Nan
    Tsiatis, Athanasios C.
    Moncur, Joel
    Ali, Amina
    Chen, Yongmei
    Knezevic, Dejan
    Maddala, Tara
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Srivastava, Shiv
    Sesterhenn, Isabell A.
    McLeod, David G.
    EUROPEAN UROLOGY, 2015, 68 (01) : 123 - 131
  • [2] Association between a 17-gene genomic prostate score and multiparametric prostate MRI in men with low- and intermediate-risk prostate cancer (PCa).
    Leapman, Michael S.
    Westphalen, Antonio C.
    Ameli, Niloufar
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Cooperberg, Matthew R.
    Carroll, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [3] A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
    Van Den Eeden, Stephen K.
    Lu, Ruixiao
    Zhang, Nan
    Quesenberry, Charles P., Jr.
    Shan, Jun
    Han, Jeong S.
    Tsiatis, Athanasios C.
    Leimpeter, Amethyst D.
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Presti, Joseph C.
    EUROPEAN UROLOGY, 2018, 73 (01) : 129 - 138
  • [4] The 17-gene Genomic Prostate Score test as a predictor of treatment selection in men with favorable intermediate-risk prostate cancer
    Margolis, E.
    Lowentritt, B. H.
    Pieczonka, C. M.
    Bennett, J. P.
    Pavlova, M.
    Zambon, J. P.
    Groskopf, J.
    Uchio, E.
    EUROPEAN UROLOGY, 2024, 85 : S1461 - S1462
  • [5] The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
    Helfand, Brian T.
    Paterakos, Michael
    Wang, Chi-Hsiung
    Talaty, Pooja
    Abranid, John
    Bennett, John
    Hallid, David W.
    Lehman, Amy
    Aboushwareb, Tamer
    PLOS ONE, 2022, 17 (09):
  • [6] Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
    Leapman, Michael S.
    Cowan, Janet E.
    Nguyen, Hao Gia
    Cooperberg, Matthew R.
    Carroll, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Utilization of 17-gene biopsy-based genomics scores in treatment decisions for low- to intermediate-risk patients with prostate cancer.
    Katz, Aaron
    Mulcahy, Megan
    Rice, Jacquelyn
    Kosinski, Kaitlin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] The 17-gene Genomic Prostate Score® assay as a predictor of biochemical recurrence in men with intermediate- and high-risk prostate cancer
    Helfand, B. T.
    Paterakos, M.
    Wang, C-H.
    Talaty, P.
    Abran, J.
    Bennett, J. P.
    Hall, D. W.
    Aboushwareb, T.
    EUROPEAN UROLOGY, 2021, 79 : S1709 - S1710
  • [9] Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
    Leapman, Michael S.
    Westphalen, Antonio C.
    Ameli, Niloufar
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Cooperberg, Matthew R.
    Carroll, Peter R.
    PLOS ONE, 2017, 12 (10):
  • [10] ASSOCIATION BETWEEN A 17-GENE GENOMIC PROSTATE SCORE AND MULTI-PARAMETRIC PROSTATE MRI IN MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER (PCA)
    Leapman, Michael
    Westphalen, Antonio
    Ameli, Niloufar
    Lawrence, Jeffrey
    Febbo, Phillip
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2015, 193 (04): : E642 - E643
123